JNPMEDI Signs Strategic Agreement with LSK Global PS To Advance Medical Data Management Platform

JNPMEDI Signs Strategic Agreement with LSK Global PS To Advance Medical Data Management Platform

JNPMEDI sings strategic agreement of research and development with LSK Global PS, Korea's leading clinical trial consignment agency (CRO), to upgrade clinical trial and medical data management services.

The two companies announced on the 1st that they signed a strategic agreement on October 27 to 'advanced medical data management platform'. Through this agreement, LSK Global PS's global clinical experience and know-how will be applied to JNPMEDI's medical data platform "Maven CDMS."

The two companies plan to release "Maven Docs" within the first quarter of next year as the first step in joint development.

Maven Docs is a solution that supports simplified document preparation through standardization of various clinical trial document forms such as clinical trial plans, case records, and electronic consent, and data linkage between documents. This is expected to dramatically improve the efficiency of document preparation work by removing unnecessary duplicate inputs and increasing the reuse of documents.

In the future, it plans to provide services in the form of an integrated solution by expanding to a LMS (Learning Management System) for clinical document education management and a monitoring system that supports inspection and fact-finding.

Industry experts predict that the market for clinical trials is rapidly changing to a Decentralized Clinical Trial (DCT) environment starting with COVID-19, and that clinical document management solutions such as "Maven Docs" will be used to digitalize documents in the medical field.